Rare diseases
Investigational molecules
Locations
Back to Germany1 clinical trial in Eberswalde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on Diffuse Large B-Cell Lymphoma (DLBCL) and its various subtypes, evaluating innovative combination therapies for elderly patients.
The study explores the effectiveness of combining acalabrutinib with standard lymphoma treatments to improve outcomes in patients over 60 and 80 years of age.
Investigation of multiple B-cell lymphoma subtypes, including rare variants such as primary cutaneous, intravascular, and mediastinal forms.
Research aims to enhance progression-free survival through targeted therapeutic strategies.
Advancing treatment protocols for elderly lymphoma patients with focus on reduced-intensity therapy combinations.
Studies evaluate modified treatment regimens designed specifically for older adults who cannot tolerate standard intensive therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
